Dear Doctor Letter (Rote-Hand-Brief) on Protelos® (strontium ranelate): Restriction of indication and recommendations for controls during administration
2014.03.11
Active substance: strontium ranelate
The company Servier Deutschland GmbH is circulating information that use of Protelos is now restricted to the treatment of severe osteoporosis in postmenopausal women and adult men with a high risk of fractures who cannot be treated with other medicinal products licensed for osteoporosis therapy.
Download DHPC / Information letter , Download_VeroeffentlichtAm_EN